Proactive Investors - Finance
09 Jul 2026, 07:19 UTC · 10w ago
Verdict
Headline leans bullish. We score AZN −0.90 across five claims.
Score contradicts the headline.
Leans bullish
From its wording — no explicit rating
−0.90strongly bearish
What the story claims
5 claims · scored −1 bearish … +1 bullish
AstraZeneca's Phase III CARDIO-TTRansform trial of the drug Wainua failed to meet its primary endpoint in treating a rare heart disease.
So whatThe failure of a major late-stage pipeline opportunity removes a significant growth driver and caused a 9% share price plunge.
More negative than 98% of claims this week
Investors are reacting to the Wainua trial failure with concerns over AstraZeneca management's credibility regarding trial design and confidence.
So whatLoss of confidence in management often leads to a valuation discount beyond the immediate financial loss of a failed drug.
Continue reading
5 related stories
More negative than 94% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 89% of claims this week
Computacenter shares rose over 13% following a positive trading update.
More positive than 76% of claims this week
Seraphim Space Investment Trust sold its portfolio company ALL.SPACE for a total value lower than its last reported carrying value.
More negative than 69% of claims this week
The National Energy System Operator issued an electricity margin notice due to tight margins caused by extreme European temperatures.
More negative than 65% of claims this week
Which stocks this story touches
More negative than 94% of ticker scores this week
Market value dropped £20 billion following the failure of the Phase III CARDIO-TTRansform trial.
More positive than 84% of ticker scores this week
Share price jumped over 13% following a positive trading update.
More negative than 87% of ticker scores this week
Company has cut its financial guidance due to operational problems.
More positive than 59% of ticker scores this week
Stock price is up 3% or more.
More positive than 59% of ticker scores this week
Stock price is up 3% or more.
More positive than 59% of ticker scores this week
Stock price is up 3% or more.
More negative than 76% of ticker scores this week
Sale of portfolio company occurred at a value below its last reported carrying value.
Near neutral — 90% of ticker scores this week are stronger
Mentioned only in the context of relative market capitalization.
Near neutral — 90% of ticker scores this week are stronger
Mentioned only in the context of relative market capitalization.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Business Wire
3d ago
−12.3%
Price agrees with the score
$166.08 vs $189.28 close before publication (Jul 8) · not market-adjusted
AZN chart →
